MATERIALS AND METHODS
The drug (abbreviated as 264CE) is a white or somewhat cream-colored and odorless powder (m.p. 125-130°C), and has a bitter taste. On use, it was dissolved in distilled water, physiological saline solution and other nutritive solutions. Toxicity : The dd-strain mice of both sexes weighing 15-20 g were used, and one group consisted of 6 mice and more than 5 groups were used for a series of experiment. After the drug was injected subcutaneously at the back, its toxic symptoms were observed. LD5o and its fiducial limit (p=0.05) were calculated from the lethality observed within 24 hours using the method of Litchfield-Wilcoxon (1). Mongrel dogs of both sexes weighing 7-12 kg were also used for the observation of toxic signs. Antitussive activity : The "coughing dog and cat" methods were used for this test. Dogs were used without anesthesia, while cats were lightly anesthetized with pentobarbital (20 mg/kg, i.p.). Cough was induced by mechanical stimulation on the mucosa of tracheal bifurcation (2) . Evaluation of the effect was done by the changes in amplitude and frequency of the tracing of cough in respiration. When the amplitude and/or the frequency were decreased by more than 20% as compared with the control, and also when such a decrease lasted for more than 20 minutes, the effect was considered to be significant. As the same animals can be used in this method repeatedly for the experiment after 2 or 3 days' rest, the errors arising from individual differences in animals were able to be kept minimal. More than 4 groups of animals were used and each group consisted of more than 5 animals. From the effectiveness of the drug given intravenously, 50% antitussive dose (abbreviated hereafter as AtD,,) and its .ducial limit were calculated by the method of Litchfield-Wilcoxon (p==0.05).
As one of the procedures for investigating the site of antitussive action, equi-active doses among various routes of administration were compared. In the dogs lightly anesthetized with pentobarbital, 264CE was given through polyethylene tubes inserted previously into the common carotid artery, the vertebral artery and the cerebello-medullar cistern, and the doses necessary to obtain the same degree of antitussive effects as that by intravenous injection were studied.
Effect on stretch receptor impulses : The chest of a guinea pig anesthetized with urethane was opened under an artificial ventilation.
The impulses from the alveolar stretch receptors were led via a bipolar silver electrode from the left vagus nerve trunk sectioned at the cervical region, and observed on an oscilloscope and recorded with a long-record ing camera. The drugs were given intraperitoneally.
Effects on the centrally evoked cough response and on the sustained inspiratory response : In cats lightly anesthetized with pentobarbital (20 mg/kg i.p.), a bipolar stainless steel electrode was inserted into the expiratory pacemaker area (3) (4) (5) , and square-wave pulses were given (parameter of stimulus : frequency 10 cps, duration 1 msec, voltage 0.5-4.0 V), to obtain spasmodic respiration like cough. It is still remained to be ascertained if this respiration is entirely identical to cough, but it is sure to be affected similarly by known antitussive as cough responses produced reflexly by peripheral stimulation.
The sustained inspiration was induced by electric stimulation (50 cps, 1 msec, 0.5-7.0 V) through a bipolar stainless steel electrode inserted into the inspiratory center of Pitts (6) Cthe inspiratory integrator of Brodie and Borison (5)D. Changes in the excitability of respiratory center due to the drug can be evaluated by the changes in the amplitude of the sustained inspiratory response and/or by the changes in the threshold of stimulus to induce the response.
In both the experiments described above, the respiratory changes were recorded by tambours connected to the tracheal cannula for tracing of intra-tracheal pressure and to thoracic and/or abdominal pneumographs.
Effect on the centrifugal respiratory pathway: The head of a cat lightly anesthetized with pentobarbital was fixed with the aid of a stereotaxic instrument. The spinal processes of the I, II, and III cervical vertebrae were resected to expose the cervical cord. In order to prevent troublesome movement of the spinal cord, a steel wire penetrating through a vertebral body was fixed tightly at both sides of the instrument and, furthermore, a spinal process of the vertebra caudal to the exposed cervical cord was clamped tightly. A bipolar electrode was inserted into one side of the lateral fascicule of the II cervical cord for stimulation (50 cps, 1 msec, 0.25-2.0 V). Changes in the movements of chest and abdominal walls indicating the contraction of respiratory muscles were recorded by thoracic and/or abdominal pneumographs (7) . When the centrifugal pathway below the stimulated area was depressed by the drug, the amplitude of contraction decreased. In many cases, the experiments were done along with the experiments described in the preceding section. Effect on the bronchial muscle : In vivo. In the rabbits anesthetized with urethane , the tonus of bronchial muscle were recorded with the method of Jackson (8) . In vitro. The tracheal muscle preparation of a guinea pig was made with the method of Takagi et al .
(10) which is a modified method of Castillo and de Beer (9) . Potentiating and prolonging effect on anesthesia : Using the dd-strain male mice weighing 14-18 g, a dose of 0.5 mg/10 g of methylhexabital-Na (MH) was administered intraperiton eally, and the duration of anesthesia was determined. Three days later , the test drug was given intraperitoneally to the same mice and, 20 minutes later , the same dose of MH was given in order to study how the duration of anesthesia was changed . Using the same mice, the similar experiment was done with codeine.
Local anesthetic activity : Surface anesthesia was examined by corneal reflex method in guinea pigs (11) ; infiltration anesthesia was examined by intracutaneous wheal method in guinea pigs (11) .
Effect on the intestines : Effect on the transportation of intestinal contents was examined with the charcoal meal test (12) . Effect on the isolated intestines was examined with the Magnus method using a strip of the ileum of a guinea pig.
Effects on respiration and blood pressure : The blood pressure in the femoral artery was recorded with the routine Hg manometer method and the respiration was recorded with a Marcy's tambour via tracheal cannula in the dogs anesthetized with barbital.
RESULTS AND DISCUSSION
I. Toxicity 1. Acute toxic symptoms Toxic symptoms appeared with doses more than 0.96 mg/10 g. A dose of 0.96 mg/10 g of 264CE caused the following symptoms: An increase of spontaneous motility follow ed by depressed behavior, a slight respiratory stimulation, stiffness of the extremities, occasional elevation of the tail, and occasional jumping. With the doses more than 1.15 mg/ 10 g, the following symptoms were anew added to those described above: A sudden bending of the body with teeth chattering and vocalization, alternate appearance of clonic convulsion and a position like embracing with the anterior extremities standing on the posterior extremities, and postictal depression. With 1.39 mg ,,/l0 g, dyspnea and respiratory arrest occurred during convulsion in two out of 6 mice. With 2.41 mg/10 g, death occurred in all six mice. As presented above, toxic signs in mice are chiefly those of central excitation and death occurred with respiratory paralysis.
LD50
The LD50 (mg/10 g) with its fiducial limit of 264CE was 1.55 (1.20-2.01) as HCI-salt, 1.38 (1.07-1.79) calculated as base. Those of other antitussives such as codeine phosphate, dihydrocodeine phosphate, dextromethorphan hydrobromide, and noscapine hydrochloride were 1.91 (1.78-2.05), 2.14 (1.56-2.94), 1.53 (1.34-1.74), and 19.8 (17.0-23.1), respectively. Therefore, the toxicity of 264CE is 0.98 times that of codeine, 1.17 times that of dihydro codeine, 0.81 times that of dextromethorphan, and 13.1 times that of noscapine, when compared in terms of those of each base.
Toxicity in dogs
A dose of 30 mg/kg of 264CE was administered intravenously to 2 dogs, while 50 mg/kg to other 2 dogs. In all cases, severe clonic convulsions began to appear during the injection and repeated. In one of the dogs receiving 50 mg/kg, respiratory arrest occurred during tonic convulsion after 5 minutes, but another case showed an almost complete recovery after 4 hours. In both the dogs receiving 30 mg/kg, clonic convulsion repeated, but a recovery was seen after 150 and 190 minutes, respectively. Although only 4 cases were studied, the intravenous lethal dose of 264CE seemed to be around 50 mg/kg (45 mg/kg calculated as its base). Since LD50 on intravenous injection of codeine phosphate is 97.8 mg/kg (69.0 mg/kg as its base), the toxicity of 264CE (base) is about 1.5 times that of codeine (base). decrease of the amplitude but it lasted only for 10 minutes, so it was concluded to be ineffective. In 3 cases including one effective case, excitation and clonic convulsion appeared for several minutes. With 9.0 mg/kg it was effective in 2 cases (30% decrease of the amplitude for 30 minutes). With 10.7 mg/kg, it was effective in 3 cases (about 50% decrease of the amplitude and about 10% decrease of the frequency for 20-45 minutes) ( Fig. 1) . At the same time, excitation and clonic convulsion were seen in all cases. With 12.8 mg/kg, it was effective in all cases (60% decrease of the amplitude and 300//0 decrease of the frequency for 30-50 minutes), but clonic convulsion increased and lasted for 15-35 minutes, though it did not develop into tonic one.
2) Cats : In 2 out of 5 cases receiving 7.5 mg/kg of 264 CE, 15% decrease was seen only in amplitude for about 10 minutes. In 3 other cases, no change occurred. With 9.0 mg/kg it was effective in 2 cases (35% decrease of the amplitude for about 20 minutes).
In 3 other cases, a slight inhibition was seen, but it was not considered to be effective. From the AtD5o of 264CE, as shown in Table 1 , its effect in dogs is 1/3-1/4 that of codeine, and much the same in cats. In dogs, convulsion was seen with the effective doses, though it was weaker than that caused by dextromethorphan or noscapine. In the case of intravenous administration, the duration of effect is not exceedingly prolonged.
Safety margin
On intravenous injection to dogs, safety margin (LD/AtDSD) was calculated to be about 5 and it is much smaller than that of codeine being 26.0.
3. Site of action 1) Comparison of equi-active doses among various routes of administration : In lightly pento barbitalized dogs, 264CE was given into the common carotid artery, the vertebral artery and the cerebello-medullar cistern, and the doses necessary to obtain the same degree of antitussive effects as that by intravenous injection were studied.
In 5 cases, the ratio of the doses (mg/kg) necessary to obtain antitussive effect to the same extent is as follows : Thus, when the routes directing the drug to the brain stem were used, much smaller dose was enough to obtain the same effect as that by intravenous injection. Therefore, the site of action is suggested to be centra?.
2) Effect on the stretch receptor impulses : The impulses from the alveolar stretch receptors act on the respiratory center, not only regulating the depth of normal respira tion (Hering-Breuer reflex), but also relating to an intensity of cough. The intensity of expiration on cough is influenced by the depth of the preceding inspiration. The deeper and faster the inspiration may be, the stronger the following expiration, that is, resulting in violent attack of cough. The antitussive action of benzonatate* is said to be due to selective local anesthesia of the receptors, resulting in a decrease of impulses (13) . The drug has a local anesthetic action a little less potent than procaine, so this action was studied if there was any relation to its antitussive activity.
In the control group, 2-3 mg/ kg of benzonatate decreased the number of the impulses, and 4 mg/kg resulted in a complete disappearance for about 25 minutes. In contrast, 264CE showed no effect in a dose range from 1 to 5 mg/kg. With an increased dose of 10 mg/kg, 3 out of 4 cases died and the rest showed a slight decrease in the number of the impulses.
3) Influence of decerebration : In order to study if the higher centers than the brain stem contribute to the antitussive activity of the drug. a mid-collicular transection at the corpora quadrigemina was done in cats, and the brain tissue rostral to the upper corpora was all scraped out. The experiments were done after the influence of operation went completely.
In 3 cats, 10 mg/kg of 264CE was injected intravenously, and its antitussive effects Fir. 2. Actions of 264CE on peripherally or centrally evoked cough response and on centrally evoked sustained inspiratory response in a cat. The cough reflex was induced either by mechanical stimulation on tracheal mucosa (M) or by electric stimulation of the medullary cough center (center). The sustained inspiration (sustained insp.) was induced by electric stimulation of inspiratory center (Pitts) in the medulla of a lightly pentobarbitalized cat (a caudal part of the cerebellum was resected.).
Trach., intratracheal pressure (expiration recorded upwards) ; Stim., stimulation either mechanically (M.) or electrically (numbers under the line denotes the voltage of stimulus). At the arrow 9.8 mg/kg of the drug was injected intravenously. 4) Effects on the centrally evoked cough response and on the sustained inspiratory response :
With an intravenous dose of 8.2 mg/kg of the drug (the lower limit of ED,,), the frequency of tracing of cough induced by mechanical stimulation was not affected but the amplitude was reduced to about a half at 5 minutes and returned to normal at 60 minutes after administration.
No change occurred both in the threshold of stimulus for cough induced by central stmulation and in the amplitude. On the other hand, threshold of sustained inspiration slightly increased without accompanying any change in amplitude.
As shown in Fig. 2, 9 .8 mg/kg (ED,o) of the drug slightly decreased the frequency of the tracing of mechanical cough and it also showed 80% decrease of the amplitude at 5 minutes and 50% decrease at 15 minutes, and returned to normal at 60 minutes after the administration.
On the other hand, the threshold for centrally evoked cough increased from 2.5 to 3.OV and the amplitude of each cough response decreased to some extent, and these changes returned to normal at 40 minutes.
No change was observed in the amplitude of sustained inspiration but the threshold elevated from 6.0 to 7.OV.
In one out of 2 cases receiving 11.7 mg/kg (the upper limit of ED,,), 50-90% decrease of both the amplitude and frequency of mechanical cough were noted ; the threshold for central cough elevated from 0.5 to 1.5V accompanying with a decrease in amplitude to some extent ; the threshold of sustained inspiration elevated from 1.0 to 1.5V accompany ing with the reduction of amplitude to greater extent. From the results presented above, 264CE decreases the sensitivity of the cough center with the AtD507 but it seems not to have a remarkable effect on the excitability of the respiratory center with the AtD50. However, it depresses the respiratory center when dose was increased more than the AtD50. 5) Effect on the centrifugal respirato)y pathway : In order to confirm that a drug acts directly on the respiratory center and the cough center, it is necessary to exclude the actions on the centrifugal respiratory pathway which extends from the spinal cord to respiratory muscles.
In 3 cases receiving 12.8 mg/kg of 264CE intravenously, coughs evoked centrally and peripherally were completely inhibited. Although the intraspinal pathway was stimulated during the time when the amplitude of sustained inspiration was slightly inhibited, no change in the magnitude of muscle contraction was seen. Thus, with the AtD100 of the drug, the centrifugal pathway of respiration seemed not to be affected.
(;) Eflect on the bronchial muscles : On cough attacks, the bronchial muscles are con tracted, and the lumen of respiratory tract is narrowed to such an extent that the air stream is greatly accelerated. A relaxation of tonus of the bronchial muscles results in a decrease in the intensity of cough. Therefore, the effect of the drug on the bronchial muscles was studied in vico and in vitro.
With intravenous injection of 1.0-5.0 mg/kg of the drug alone, no effect was seen on the muscular tone recorded with the method of Jackson (8) . The similar effect was seen with an increased dose of 10 mg/kg, but some cases died of hypotension.
With 10 /-tg/kg of histamine given intravenously, the amplitude of the tracing of respiration decreased markedly, becoming 10-20% of that seen before the administration. With the pretreatment of 1.0-5.0 mg/kg of 264CE, no effect was seen, but the contraction was rather strengthened in some cases given 5.0 mg/kg.
In vitro experiment, a weak relaxation was observed with concentrations more than 2 x 10' g/ ml of 264CE alone. Antiacetylcholine, anti-BaC12 and antihistamine actions were 1/100,000 of atropine, 1/150 of papaverine, and 1/800 of diphenhydramine, respectively.
From the data above, it is concluded that 264CE has neither a direct action on the bronchial muscles nor the action preventing the contraction induced by histamine in rabbits, and that it does not have any significant action on the isolated bronchial muscles either. Therefore, the site of antitussive action of the drug is concluded to be in the cough center. Doses up to 1/2 LD,, were administered, but no significant effect was seen.
IV. Local Anesthetic Action
The drug was 4/5 as potent as procaine in superficial anesthesia and 7/10 as potent as procaine in infiltration anesthesia both in guinea pigs.
V. Actions on the Intestines
Inhibitory effect on transportation of intestinal contents
On clinical application of narcotic antitussives such as codeine, constipation is one of the important side-effects. So, an inhibitory effect of the drug on the transportation of intestinal contents in mice was studied.
Using 6 groups for 264CE and 5 groups for codeine, the ED,, with fiducial limit were 0.33 (0.20-0.54) mg/10 g and 0.11 (0.08--0.14) mg/10 g, respectively.
There was a significant difference between the two at a level of p=0.05. Thus, the inhibitory effect of 264CE
is only 1/3 that of codeine.
Actions on the isolated intestines
Anti-ACh, anti-BaC12j and antihistamine effects were studied using the ileum of guinea pigs. On comparing with effects of atropine, papaverine and diphenhydramine, its anti-BaCl2 action was 1/4-1/5 that of papaverine, while the anti-ACh and antihistamine effects were 1/5,000 that of atropine and 1/50-1/60 that of diphenhydramine, respectively.
VI. Actions on the Respiration and Blood Pressure
Intravenous' doses more than 0.5 mg/kg of 264CE caused a transitory blood pressure fall in the dogs anesthetized with barbital and the degree of fall depended upon the doses given. Respiration showed an increase concomitantly with the fall of blood pressure.
With 10 mg/kg (equals to the AtD,o in unanesthetized dogs), the blood pressure fell by 50 mmHg during the injection. Increase in amplitude and frequency of respiration were associated with the decrease in blood pressure and it persisted for 3 to 4 minutes , and then respiratory depression occurred. Respiratory depression, especially decrease in frequency was most remarkable at 30 minutes after administration . Blood pressure began to rise at 30 seconds and returned to the pretreatment level within 30 minutes , though fluctuation of pressure associated with respiratory depression was observed . The respira tion returned to the pretreatment level within 90 minutes , as shown in Fig. 3 . With 20 mg/kg, the blood pressure precipitously fell already during the injection and it was followed by apnea for several seconds . Then, respiratory stimulation developed. The blood pressure, however, continued to fall, and the respiration was also inhibited gradually, followed by respiratory arrest in 2 minutes. All the dogs used died with this dose.
On the other hand, intravenous doses less than 2.0 mg/kg of codeine showed no change in respiration and blood pressure. With the doses more than 5 .0 mg/kg, the blood pressure fell temporarily, and the respiration increased concomitantly with the fall of blood pressure, followed by long-lasting depression . With 20 mg/kg, however, no death occurred, though the changes in respiration and blood pressure were remarkable.
Thus, 264CE seems to have more remarkable influences on respiration and blood pressure, especially on the latter, than codeine. 
SUMMARY
The antitussive action and its site of action of 2-allyloxy-4-chloro-N-(2-diethylamino ethyl) benzamide HC1 (264CE) were studied. The antitussive effect was 1/3-1/4 as potent as codeine in dogs and cats. The site of antitussive action was con termed to be the cough center itself, but its mechanism of antitussive effect is different from those of narcotic ones.
The drug is as toxic as codeine in mice, but it is more toxic than codeine in dogs.
Other pharmacological properties related to its main effect such as actions on the CNS, intestines, respiration and blood pressure, and local anesthetic action were also described.
